Cargando…

Does Information from the Parkinson KinetiGraph™ (PKG) Influence the Neurologist’s Treatment Decisions?—An Observational Study in Routine Clinical Care of People with Parkinson’s Disease

Management of Parkinson’s disease traditionally relies solely on clinical assessment. The PKG objectively measures affected persons’ movements in daily life. The present study evaluated how often PKG data changed treatment decisions in routine clinical care and to what extent the clinical assessment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sundgren, Mathias, Andréasson, Mattias, Svenningsson, Per, Noori, Rose-Marie, Johansson, Anders
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227056/ https://www.ncbi.nlm.nih.gov/pubmed/34198780 http://dx.doi.org/10.3390/jpm11060519

Ejemplares similares

More Sensitive Identification for Bradykinesia Compared to Tremors in Parkinson’s Disease Based on Parkinson’s KinetiGraph (PKG)
por: Chen, Lina, et al.
Publicado: (2020)

Comparing Objective and Subjective Measures of Parkinson's Disease Using the Parkinson's KinetiGraph
por: Knudson, Mei, et al.
Publicado: (2020)

Identification and quantitative assessment of motor complications in Parkinson’s disease using the Parkinson’s KinetiGraph™
por: Qu, Yan, et al.
Publicado: (2023)

Introducing the Parkinson’s KinetiGraph into Routine Parkinson’s Disease Care: A 3-Year Single Centre Experience
por: Dominey, Thea, et al.
Publicado: (2020)

The Use of Data from the Parkinson’s KinetiGraph to Identify Potential Candidates for Device Assisted Therapies
por: Khodakarami, Hamid, et al.
Publicado: (2019)

Qualitative Evaluation of the Personal KinetiGraph(TM) Movement Recording System in a Parkinson’s Clinic
por: Santiago, Anthony, et al.
Publicado: (2019)

Objective measurement in Parkinson’s disease: a descriptive analysis of Parkinson’s symptom scores from a large population of patients across the world using the Personal KinetiGraph®
por: Pahwa, Rajesh, et al.
Publicado: (2020)

Clinical correlates of movement disorders in adult Niemann-Pick type C patients measured via a Personal KinetiGraph
por: El-Masri, Shaddy, et al.
Publicado: (2022)

Parkinson’s Kinetigraph in the Selection of Levodopa-Carbidopa Intestinal Gel for Motor Fluctuations Refractory to Deep Brain Stimulation
por: Noui, Yassine, et al.
Publicado: (2021)

PKG Movement Recording System Use Shows Promise in Routine Clinical Care of Patients With Parkinson's Disease
por: Joshi, Rajeshree, et al.
Publicado: (2019)

MCEE Mutations in an Adult Patient with Parkinson’s Disease, Dementia, Stroke and Elevated Levels of Methylmalonic Acid
por: Andréasson, Mattias, et al.
Publicado: (2019)

Update on the Management of Parkinson's Disease for General Neurologists
por: Pirtošek, Zvezdan, et al.
Publicado: (2020)

[(18)F]FE-PE2I DAT correlates with Parkinson’s disease duration, stage, and rigidity/bradykinesia scores: a PET radioligand validation study
por: Kerstens, Vera S., et al.
Publicado: (2023)

Simplified quantification of [(18)F]FE-PE2I PET in Parkinson’s disease: Discriminative power, test–retest reliability and longitudinal validity during early peak and late pseudo-equilibrium
por: Brumberg, Joachim, et al.
Publicado: (2020)

Reliability of dopamine transporter PET measurements with [(18)F]FE-PE2I in patients with Parkinson’s disease
por: Kerstens, Vera S., et al.
Publicado: (2020)

Do neurologists in Germany adhere to the national Parkinson’s disease guideline?
por: Schröder, Sabrina, et al.
Publicado: (2011)

Neurologists’ diagnostic accuracy of depression and cognitive problems in patients with parkinsonism
por: Bouwmans, Angela EP, et al.
Publicado: (2012)

Glycosphingolipid Changes in Plasma in Parkinson's Disease Independent of Glucosylceramide Levels
por: te Vruchte, Danielle, et al.
Publicado: (2022)

Pupil light reflex dynamics in Parkinson’s disease
por: Tsitsi, Panagiota, et al.
Publicado: (2023)

Discussing sexuality with patients with Parkinson’s disease: a survey among Dutch neurologists
por: van Hees, Petra J. M., et al.
Publicado: (2016)

Discussing sexuality with Parkinson’s disease patients: a multinational survey among neurologists
por: de Rooy, F. B. B., et al.
Publicado: (2019)

Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing
por: Tan, Deck Khong, et al.
Publicado: (2020)

Reading Alterations in Parkinson's Disease Indicate Worse Cognitive Status
por: Tsitsi, Panagiota, et al.
Publicado: (2023)

Fixation Duration and Pupil Size as Diagnostic Tools in Parkinson’s Disease
por: Tsitsi, Panagiota, et al.
Publicado: (2021)

Antidepressant-like properties of sarizotan in experimental Parkinsonism
por: Zhang, Xiaoqun, et al.
Publicado: (2011)

Invalid Self-Assessment of Olfactory Functioning in Parkinson's Disease Patients May Mislead the Neurologist
por: Schmidt, Nele, et al.
Publicado: (2020)

The pretender of Parkinson's disease: What neurologists need to know about functional movement disorders
por: Hao, Xiaodi, et al.
Publicado: (2021)

Wide-field mosaics of the corneal subbasal nerve plexus in Parkinson’s disease using in vivo confocal microscopy
por: Badian, Reza A., et al.
Publicado: (2021)

Safety and tolerability of IRL790 in Parkinson’s disease with levodopa-induced dyskinesia—a phase 1b trial
por: Svenningsson, Per, et al.
Publicado: (2018)

Consensus on the Definition of Advanced Parkinson's Disease: A Neurologists-Based Delphi Study (CEPA Study)
por: Luquin, Maria-Rosario, et al.
Publicado: (2017)

Longitudinal DAT changes measured with [(18)F]FE-PE2I PET in patients with Parkinson’s disease; a validation study
por: Kerstens, V.S., et al.
Publicado: (2023)

Improved Dissolution and Pharmacokinetics of Abiraterone through KinetiSol(®) Enabled Amorphous Solid Dispersions
por: Gala, Urvi, et al.
Publicado: (2020)

Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
por: Wallin, Johan, et al.
Publicado: (2021)

Parkinson’s disease with restless legs syndrome—an in vivo corneal confocal microscopy study
por: Andréasson, Mattias, et al.
Publicado: (2021)

Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease
por: Bergquist, Filip, et al.
Publicado: (2022)

Vertical saccades and antisaccades: complementary markers for motor and cognitive impairment in Parkinson’s disease
por: Waldthaler, Josefine, et al.
Publicado: (2019)

Genetic Variations and mRNA Expression of NRF2 in Parkinson's Disease
por: Ran, Caroline, et al.
Publicado: (2017)

Impaired migratory phenotype of CD4(+) T cells in Parkinson’s disease
por: Mamula, Dejan, et al.
Publicado: (2022)

Cortex-wide topography of 1/f-exponent in Parkinson’s disease
por: Helson, Pascal, et al.
Publicado: (2023)

Feasibility Aspects of Exploring Exercise-Induced Neuroplasticity in Parkinson's Disease: A Pilot Randomized Controlled Trial
por: Johansson, Hanna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_343gbpqluminrcquu4mn497563